Do analysts rate AEMD or MBAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, AEMD or MBAI?

Check-Cap is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aethlon Medical N/A N/A -$13.39M -$14.69 N/A Check-Cap N/A N/A $4.14M -$2.77 N/A

Is AEMD or MBAI more profitable?

Check-Cap's return on equity of 0.00% beat Aethlon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -219.39% -164.33% Check-Cap N/A N/A N/A

Does the media refer more to AEMD or MBAI?

In the previous week, Aethlon Medical had 1 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.94 beat Aethlon Medical's score of 0.54 indicating that Check-Cap is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AEMD or SURG?

SurgePays has a consensus target price of $5.00, suggesting a potential upside of 851.29%. Given SurgePays' stronger consensus rating and higher possible upside, analysts clearly believe SurgePays is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 SurgePays 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Is AEMD or SURG more profitable?

Aethlon Medical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. Aethlon Medical's return on equity of -219.39% beat SurgePays' return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -219.39% -164.33% SurgePays -64.91% -967.32% -310.16%

Does the media refer more to AEMD or SURG?

In the previous week, Aethlon Medical had 1 more articles in the media than SurgePays. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for SurgePays. SurgePays' average media sentiment score of 0.77 beat Aethlon Medical's score of 0.54 indicating that SurgePays is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SurgePays 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AEMD or ALUR?

Allurion Technologies has a consensus price target of $3.00, suggesting a potential upside of 250.88%. Given Allurion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Allurion Technologies is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Allurion Technologies 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor AEMD or ALUR?

In the previous week, Aethlon Medical had 2 more articles in the media than Allurion Technologies. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Allurion Technologies. Allurion Technologies' average media sentiment score of 1.42 beat Aethlon Medical's score of 0.54 indicating that Allurion Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Allurion Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend LFWD or AEMD?

Lifeward currently has a consensus price target of $10.00, suggesting a potential upside of 37.36%. Given Lifeward's stronger consensus rating and higher possible upside, research analysts clearly believe Lifeward is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifeward 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is LFWD or AEMD more profitable?

Aethlon Medical has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Aethlon Medical's return on equity of -219.39% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -123.66% -243.14% -97.39% Aethlon Medical N/A -219.39% -164.33%

Do analysts rate SINT or AEMD?

Sintx Technologies currently has a consensus target price of $11.00, indicating a potential upside of 391.07%. Given Sintx Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Sintx Technologies is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media prefer SINT or AEMD?

In the previous week, Aethlon Medical had 1 more articles in the media than Sintx Technologies. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat Aethlon Medical's score of 0.54 indicating that Sintx Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aethlon Medical (AEMD) Competitors

$2.10 -0.11 (-4.98%)

Closing price 04:00 PM Eastern

Extended Trading

$2.01 -0.09 (-4.29%)

As of 07:53 PM Eastern

Compare

AEMD vs. MBAI, SURG, ALUR, LFWD, and SINT

Should you buy Aethlon Medical stock or one of its competitors? MarketBeat compares Aethlon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aethlon Medical include Check-Cap (MBAI), SurgePays (SURG), Allurion Technologies (ALUR), Lifeward (LFWD), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry.

How does Aethlon Medical compare to Check-Cap?

Aethlon Medical (NASDAQ:AEMD) and Check-Cap (NASDAQ:MBAI) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

Aethlon Medical has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market. Comparatively, Check-Cap has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

In the previous week, Aethlon Medical had 1 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.94 beat Aethlon Medical's score of 0.54 indicating that Check-Cap is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Check-Cap's return on equity of 0.00% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-219.39%	-164.33%
Check-Cap	N/A	N/A	N/A

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Check-Cap is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A
Check-Cap	N/A	N/A	$4.14M	-$2.77	N/A

Summary

Aethlon Medical beats Check-Cap on 6 of the 11 factors compared between the two stocks.

How does Aethlon Medical compare to SurgePays?

Aethlon Medical (NASDAQ:AEMD) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Aethlon Medical has higher earnings, but lower revenue than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A
SurgePays	$56.96M	0.23	-$36.07M	-$1.94	N/A

In the previous week, Aethlon Medical had 1 more articles in the media than SurgePays. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for SurgePays. SurgePays' average media sentiment score of 0.77 beat Aethlon Medical's score of 0.54 indicating that SurgePays is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SurgePays	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Aethlon Medical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. Aethlon Medical's return on equity of -219.39% beat SurgePays' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-219.39%	-164.33%
SurgePays	-64.91%	-967.32%	-310.16%

Aethlon Medical has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, SurgePays has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

SurgePays has a consensus target price of $5.00, suggesting a potential upside of 851.29%. Given SurgePays' stronger consensus rating and higher possible upside, analysts clearly believe SurgePays is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
SurgePays	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 6.9% of SurgePays shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by insiders. Comparatively, 29.1% of SurgePays shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

SurgePays beats Aethlon Medical on 8 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Allurion Technologies?

Aethlon Medical (NASDAQ:AEMD) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Allurion Technologies has a consensus price target of $3.00, suggesting a potential upside of 250.88%. Given Allurion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Allurion Technologies is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Allurion Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Allurion Technologies has higher revenue and earnings than Aethlon Medical. Allurion Technologies is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A
Allurion Technologies	$17.21M	0.74	-$7.20M	-$1.75	N/A

In the previous week, Aethlon Medical had 2 more articles in the media than Allurion Technologies. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Allurion Technologies. Allurion Technologies' average media sentiment score of 1.42 beat Aethlon Medical's score of 0.54 indicating that Allurion Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Allurion Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are owned by institutional investors. 0.7% of Aethlon Medical shares are owned by company insiders. Comparatively, 8.1% of Allurion Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Aethlon Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -199.96%. Allurion Technologies' return on equity of 0.00% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-219.39%	-164.33%
Allurion Technologies	-199.96%	N/A	-77.13%

Aethlon Medical has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, Allurion Technologies has a beta of -0.18, meaning that its share price is 118% less volatile than the broader market.

Summary

Allurion Technologies beats Aethlon Medical on 12 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Lifeward?

Lifeward (NASDAQ:LFWD) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

Aethlon Medical has lower revenue, but higher earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.93	-$19.91M	-$19.66	N/A
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A

In the previous week, Lifeward had 3 more articles in the media than Aethlon Medical. MarketBeat recorded 6 mentions for Lifeward and 3 mentions for Aethlon Medical. Lifeward's average media sentiment score of 1.47 beat Aethlon Medical's score of 0.54 indicating that Lifeward is being referred to more favorably in the media.

Company	Overall Sentiment
Lifeward	Positive
Aethlon Medical	Positive

Lifeward has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

Aethlon Medical has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Aethlon Medical's return on equity of -219.39% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
Aethlon Medical	N/A	-219.39%	-164.33%

26.8% of Lifeward shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 1.5% of Lifeward shares are held by insiders. Comparatively, 0.7% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Lifeward currently has a consensus price target of $10.00, suggesting a potential upside of 37.36%. Given Lifeward's stronger consensus rating and higher possible upside, research analysts clearly believe Lifeward is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Lifeward beats Aethlon Medical on 9 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Sintx Technologies?

Sintx Technologies (NASDAQ:SINT) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Sintx Technologies currently has a consensus target price of $11.00, indicating a potential upside of 391.07%. Given Sintx Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Sintx Technologies is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Aethlon Medical had 1 more articles in the media than Sintx Technologies. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat Aethlon Medical's score of 0.54 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Sintx Technologies has higher revenue and earnings than Aethlon Medical. Sintx Technologies is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	9.49	-$10.36M	-$5.07	N/A
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A

Aethlon Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Aethlon Medical's return on equity of -219.39% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,058.60%	-366.49%	-115.04%
Aethlon Medical	N/A	-219.39%	-164.33%

Sintx Technologies has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

Summary

Sintx Technologies beats Aethlon Medical on 10 of the 15 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.47M	$49.51B	$6.47B	$12.54B
Dividend Yield	N/A	1.81%	2.69%	5.22%
P/E Ratio	-0.14	22.65	22.39	24.18
Price / Sales	N/A	0.60	520.79	112.26
Price / Cash	N/A	22.75	41.34	57.13
Price / Book	0.08	2.57	9.84	6.72
Net Income	-$13.39M	$1.46B	$3.57B	$337.19M
7 Day Performance	-31.60%	-4.18%	-1.16%	0.48%
1 Month Performance	-8.70%	3.35%	3.85%	5.07%
1 Year Performance	-92.50%	-9.06%	27.40%	34.25%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	0.9722 of 5 stars	$2.10 -5.0%	N/A	-92.3%	$3.47M	N/A	N/A	10	News Coverage Short Interest Increase Gap Down
MBAI Check-Cap	0.2701 of 5 stars	$1.72 -3.4%	N/A	N/A	$12.97M	N/A	N/A	80	Gap Down
SURG SurgePays	3.0793 of 5 stars	$0.51 +0.7%	$5.00 +889.1%	-81.3%	$12.61M	$56.96M	N/A	40	Short Interest Decrease
ALUR Allurion Technologies	1.954 of 5 stars	$0.80 -3.5%	$3.00 +275.0%	-73.5%	$12.00M	$17.21M	N/A	501	News Coverage Positive News Gap Up
LFWD Lifeward	2.069 of 5 stars	$6.98 -1.0%	$10.00 +43.3%	-47.8%	$10.77M	$20.92M	N/A	60	Positive News Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. MBAI, SURG, ALUR, LFWD, and SINT

How does Aethlon Medical compare to Check-Cap?

Summary

How does Aethlon Medical compare to SurgePays?

Summary

How does Aethlon Medical compare to Allurion Technologies?

Summary

How does Aethlon Medical compare to Lifeward?

Summary

How does Aethlon Medical compare to Sintx Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. MBAI, SURG, ALUR, LFWD, and SINT

How does Aethlon Medical compare to Check-Cap?

Which has more risk and volatility, AEMD or MBAI?

Does the media refer more to AEMD or MBAI?

Is AEMD or MBAI more profitable?

Do institutionals & insiders believe in AEMD or MBAI?

Do analysts rate AEMD or MBAI?

Which has preferable valuation and earnings, AEMD or MBAI?

Summary

How does Aethlon Medical compare to SurgePays?

Which has preferable valuation & earnings, AEMD or SURG?

Does the media refer more to AEMD or SURG?

Is AEMD or SURG more profitable?

Which has more volatility & risk, AEMD or SURG?

Do analysts prefer AEMD or SURG?

Do institutionals and insiders believe in AEMD or SURG?

Summary

How does Aethlon Medical compare to Allurion Technologies?

Do analysts recommend AEMD or ALUR?

Which has preferable earnings & valuation, AEMD or ALUR?

Does the media favor AEMD or ALUR?

Do institutionals & insiders hold more shares of AEMD or ALUR?

Is AEMD or ALUR more profitable?

Which has more volatility & risk, AEMD or ALUR?

Summary

How does Aethlon Medical compare to Lifeward?

Which has preferable valuation & earnings, LFWD or AEMD?

Does the media prefer LFWD or AEMD?

Which has more volatility and risk, LFWD or AEMD?

Is LFWD or AEMD more profitable?

Do institutionals and insiders hold more shares of LFWD or AEMD?

Do analysts recommend LFWD or AEMD?

Summary

How does Aethlon Medical compare to Sintx Technologies?

Do analysts rate SINT or AEMD?

Does the media prefer SINT or AEMD?

Do insiders and institutionals have more ownership in SINT or AEMD?

Which has preferable valuation and earnings, SINT or AEMD?

Is SINT or AEMD more profitable?

Which has more risk and volatility, SINT or AEMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools